基本資料
種類: ETF
費用比率%: 0.60
資產淨值: 31.72
成立日期: 11/12/2017
 
分析
市值分佈:
74.04%
大市值
3.95%
中市值
1.36%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 14/11/2026 05:06) 總持有投資項目: 314  
0%
 
100%
     10大 (23.97%)
代號 名稱 佔比% ▼ 持有日期
TYRATyra Biosciences0.0530/10/2026
JBIOJade Biosciences Inc0.0530/10/2026
ANNXAnnexon0.0530/10/2026
INBXInhibrx Biosciences Inc.0.0530/10/2026
GLUEMonte Rosa Therapeutics0.0530/10/2026
ORICOric Pharmaceuticals0.0430/10/2026
ARDXArdelyx0.0430/10/2026
VORVor Biopharma Inc0.0430/10/2026
COAGHemab Therapeutics Holdings, Inc.0.0430/10/2026
TSHATaysha Gene Therapies0.0430/10/2026
TDYTeledyne Technologies0.0430/10/2026
KEYSKeysight Technologies0.0430/10/2026
SOLVSolventum Corp0.0430/10/2026
JANXJanux Therapeutics0.0430/10/2026
DUOLDuolingo0.0430/10/2026
BAXBaxter International0.0430/10/2026
ROPRoper Technologies0.0430/10/2026
PODDInsulet Corp0.0430/10/2026
CGEMCullinan Therapeutics0.0430/10/2026
TECHBio-Techne Corp0.0430/10/2026
  1    2    3    4    5    6    7    8    9    10    11   12    13    14    15    16  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.